{Reference Type}: Congress
{Title}: Report From the Second Global Scientific Conference on Clinical Trial Design and Outcome Measures for RDH12-Associated Inherited Retinal Degeneration.
{Author}: Cerolini S;Bennett J;Leroy BP;Durham T;Coates C;Pletcher MT;Lacey S;Aleman TS;
{Journal}: Transl Vis Sci Technol
{Volume}: 13
{Issue}: 8
{Year}: 2024 Aug 1
{Factor}: 3.048
{DOI}: 10.1167/tvst.13.8.17
{Abstract}: <B>UNASSIGNED: </B>A multi-stakeholder, patient centric approach will be critical to the design of future successful clinical trials with outcome measures relevant to the RDH12-IRD population.